Other Names for this Disease
- Short stature with delayed bone age, expressive language delay, a triangular face with a prominent nose and deep-set eyes
- Pelletier-Leisti syndrome
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
The treatment of Floating-Harbor syndrome is directed toward the specific symptoms that are present in each individual. Treatment may require the coordinated effort of a team of specialists. Early developmental intervention is important to ensure that affected children reach their potential; most affected children will benefit from occupational, physical, and speech therapy. Additional social and/or vocational services may also be beneficial. In some cases, behavior management strategies may be needed. Growth hormone has been used in some cases to treat individuals with FHS, though there is limited information on the effectiveness of growth hormone therapy in this population. Annual evaluations of vision, hearing, blood pressure, and kidney function are suggested. Sonographic evaluation for renal (kidney) cysts in teenage/adult years is also indicated.
Last updated: 4/29/2016
- Nikkel, Sarah. Floating Harbor Syndrome. National Organization for Rare Disorders (NORD). 2014; http://rarediseases.org/rare-diseases/floating-harbor-syndrome. Accessed 4/29/2016.
- Nowaczyk, Malgorzata. Floating-Harbor syndrome. GeneReviews. January, 2013; http://www.ncbi.nlm.nih.gov/books/NBK114458. Accessed 4/29/2016.